ESR1 and myocarditis: Studies determined that protection during experimental CVB3-induced myocarditis depends on signaling through ERα as disease susceptibility is increased in ERα knockout mice while infected male mice treated with the specific ERα agonist, propylpyrazoletriol (PPT) were protected (50).